Market Value142,011,000
Total Holdings60
File Date2022-11-28
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KNSA / Kiniksa Pharmaceuticals, Ltd.
MASI / Masimo Corporation
DCGO / DocGo Inc.
BDSX / Biodesix, Inc.
YTEN / Yield10 Bioscience, Inc.
SIEN / Sientra, Inc.
CNCE / Concert Pharmaceuticals Inc
CLR / Continental Resources Inc (OKLA)
TPTX / Turning Point Therapeutics Inc
IMGN / ImmunoGen, Inc.
ETRN / Equitrans Midstream Corporation
PXD / Pioneer Natural Resources Company
SILK / Silk Road Medical, Inc
GTHX / G1 Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
OVV / Ovintiv Inc.
ALKS / Alkermes plc
TSVT / 2seventy bio, Inc.
ATEC / Alphatec Holdings, Inc.
CGEM / Cullinan Therapeutics, Inc.
BHVN / Biohaven Ltd.
ARVN / Arvinas, Inc.
UTHR / United Therapeutics Corporation
XNCR / Xencor, Inc.
CFRX / ContraFect Corp
CCXI / ChemoCentryx Inc
HROW / Harrow, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
FOLD / Amicus Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
ELUT / Elutia Inc.
XENE / Xenon Pharmaceuticals Inc.
PHR / Phreesia, Inc.
CYTK / Cytokinetics, Incorporated
PRTA / Prothena Corporation plc
KALV / KalVista Pharmaceuticals, Inc.
FHTX / Foghorn Therapeutics Inc.
PTGX / Protagonist Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CORT / Corcept Therapeutics Incorporated
QDEL / QuidelOrtho Corporation
INBX.V / Inhibrx, Inc.
IRTC / iRhythm Technologies, Inc.
LSF / Laird Superfood, Inc.
NARI / Inari Medical, Inc.
ALBO / Albireo Pharma Inc
BMY / Bristol-Myers Squibb Company
AWH / Aspira Women's Health Inc.
ANGN / Angion Biomedica Corp
ISEE / IVERIC bio Inc
AVEO / AVEO Pharmaceuticals Inc
STOK / Stoke Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
NBIX / Neurocrine Biosciences, Inc.
NKTR / Nektar Therapeutics
SLNO / Soleno Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
AXDX / Accelerate Diagnostics, Inc.
IFRX / InflaRx N.V.
BLUE / bluebird bio, Inc.